Aurora Cannabis (ACB) Expands Global Footprint With New Europe and Australia Deals

Aurora Cannabis Inc. (NASDAQ:ACB) ranks among the best sin stocks to buy in 2026. Aurora Cannabis Inc. (NASDAQ:ACB) has recently been making significant market growth in Europe and Australia, with the company stating on December 2 that its subsidiary, MedReleaf Australia, has signed a distribution agreement with Leafio, Montu Australia’s wholesale arm.

The partnership intends to give medical professionals training materials while expanding patient access to medical cannabis products throughout Australia. Leafio agreed to market Aurora’s medical cannabis portfolio, which includes brands like MedReleaf, CraftPlant, Aurora, Whistler Cannabis Co., and IndiMed.

In addition, over a week later, on December 11, Aurora Cannabis Inc. (NASDAQ:ACB) launched Black Jelly, a patented cannabis cultivar, on the Polish medicinal market. The new high-potency product, which contains 27% THC and less than 1% CBD, is made in Aurora’s Canadian GACP and EU-GMP-certified facilities and joins Farm Gas and Sourdough in the Cannabis flos Aurora range.

The company stated that Black Jelly is immediately available to Polish prescribers and highlighted its genetics program, hang-drying and curing methods, and more than a decade of experience in the global medical market.

Aurora Cannabis Inc. (NASDAQ:ACB) is a company that produces, distributes, and sells cannabis and cannabis-derived products in Canada and on the international stage. The company has a dual focus, serving both the medical and consumer segments of the cannabis market.

While we acknowledge the potential of ACB to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ACB and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds.

Disclosure: None. This article is originally published at Insider Monkey.